| Product Code: ETC5260596 | Publication Date: Nov 2023 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The Ireland Contraceptive Drugs Market is projected to witness mixed growth rate patterns during 2025 to 2029. Although the growth rate starts strong at 0.02% in 2025, it steadily loses momentum, ending at 0.01% by 2029.

Ireland's Contraceptive Drugs market is anticipated to experience a stable growth rate of 0.01% by 2027, reflecting trends observed in the largest economy Germany, followed by United Kingdom, France, Italy and Russia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Contraceptive Drugs Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Contraceptive Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Contraceptive Drugs Market - Industry Life Cycle |
3.4 Ireland Contraceptive Drugs Market - Porter's Five Forces |
3.5 Ireland Contraceptive Drugs Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Ireland Contraceptive Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Contraceptive Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about family planning and contraception methods |
4.2.2 Rising adoption of long-acting reversible contraceptives (LARCs) |
4.2.3 Government initiatives to promote sexual health and family planning |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of contraceptive drugs |
4.3.2 Social stigma and cultural barriers associated with contraceptive use |
4.3.3 Competition from alternative contraceptive methods such as condoms and intrauterine devices (IUDs) |
5 Ireland Contraceptive Drugs Market Trends |
6 Ireland Contraceptive Drugs Market Segmentations |
6.1 Ireland Contraceptive Drugs Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Ireland Contraceptive Drugs Market Revenues & Volume, By Oral, 2021-2031F | 6.1.4 Ireland Contraceptive Drugs Market Revenues & Volume, By Injectable, 2021-2031F |
6.1.4 Ireland Contraceptive Drugs Market Revenues & Volume, By Patches, 2021-2031F |
6.2 Ireland Contraceptive Drugs Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Ireland Contraceptive Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021-2031F |
6.2.3 Ireland Contraceptive Drugs Market Revenues & Volume, By Retail Pharmacy, 2021-2031F |
6.2.4 Ireland Contraceptive Drugs Market Revenues & Volume, By Clinics, 2021-2031F |
6.2.5 Ireland Contraceptive Drugs Market Revenues & Volume, By Online Channel, 2021-2031F |
6.2.6 Ireland Contraceptive Drugs Market Revenues & Volume, By Public Channel & NGOs, 2021-2031F |
6.2.7 Ireland Contraceptive Drugs Market Revenues & Volume, By Others, 2021-2031F |
7 Ireland Contraceptive Drugs Market Import-Export Trade Statistics |
7.1 Ireland Contraceptive Drugs Market Export to Major Countries |
7.2 Ireland Contraceptive Drugs Market Imports from Major Countries |
8 Ireland Contraceptive Drugs Market Key Performance Indicators |
8.1 Number of individuals attending sexual health clinics for contraceptive consultations |
8.2 Percentage of women opting for LARCs over traditional contraceptive methods |
8.3 Government funding allocated to sexual health and family planning programs |
9 Ireland Contraceptive Drugs Market - Opportunity Assessment |
9.1 Ireland Contraceptive Drugs Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Ireland Contraceptive Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Contraceptive Drugs Market - Competitive Landscape |
10.1 Ireland Contraceptive Drugs Market Revenue Share, By Companies, 2024 |
10.2 Ireland Contraceptive Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |